Casper G Schalkwijk Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

1/2022	The cardiometabolic depression subtype and its association with clinical characteristics: The Maastricht Study.
12/2018	Complement C3 and C4, but not their regulators or activated products, are associated with incident metabolic syndrome: the CODAM study.
1/2016	Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study.
1/2013	Multiple inflammatory biomarker detection in a prospective cohort study: a cross-validation between well-established single-biomarker techniques and an electrochemiluminescense-based multi-array platform.
1/2012	Human plasma complement C3 is independently associated with coronary heart disease, but only in heavy smokers (the CODAM study).
9/2011	Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease.
7/2011	The association between the metabolic syndrome and alanine amino transferase is mediated by insulin resistance via related metabolic intermediates (the Cohort on Diabetes and Atherosclerosis Maastricht [CODAM] study).
12/2006	PAI-1 inhibition in obesity and the metabolic syndrome: a promising therapeutic strategy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Casper G Schalkwijk Research Topics

Disease

75	Inflammation (Inflammations) 01/2023 - 03/2002
67	Type 2 Diabetes Mellitus (MODY) 01/2024 - 06/2003
47	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 03/2004
31	Atherosclerosis 02/2023 - 03/2002
31	Insulin Resistance 01/2023 - 03/2002
21	Obesity 01/2024 - 03/2002
17	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2022 - 12/2002
13	Prediabetic State (Prediabetes) 11/2023 - 01/2017
13	Hypertension (High Blood Pressure) 10/2022 - 09/2008
12	Albuminuria 01/2022 - 01/2006
11	Fibrosis (Cirrhosis) 08/2015 - 09/2004
10	Hyperglycemia 11/2020 - 12/2002
9	Neoplasms (Cancer) 02/2024 - 06/2005
9	Non-alcoholic Fatty Liver Disease 01/2023 - 07/2011
9	Weight Loss (Weight Reduction) 04/2022 - 01/2017
8	Overweight 01/2023 - 11/2014
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 12/2006
8	Heart Failure 01/2021 - 12/2007
8	Diabetic Nephropathies (Diabetic Nephropathy) 06/2013 - 05/2002
6	Myocardial Infarction 11/2021 - 05/2006
6	Chronic Kidney Failure (Chronic Renal Failure) 10/2020 - 06/2005
5	Hyperemia 10/2022 - 01/2015
5	Glucose Intolerance 01/2022 - 07/2007
5	Diabetes Complications 01/2019 - 05/2008
5	Diabetic Angiopathies (Diabetic Angiopathy) 04/2012 - 05/2002
4	Hypoxia (Hypoxemia) 05/2024 - 11/2010
4	Rupture 01/2023 - 04/2014
4	Diabetes Mellitus 11/2022 - 01/2008
4	Abdominal Obesity 01/2022 - 04/2011
4	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 01/2020
4	Chronic Renal Insufficiency 10/2020 - 01/2019
3	Neoplasm Metastasis (Metastasis) 02/2024 - 10/2016
3	Fatty Liver 03/2023 - 01/2008
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 03/2016
3	Stroke (Strokes) 01/2021 - 05/2006
3	Fructose Intolerance (Intolerance, Fructose) 06/2020 - 11/2019
3	Renal Insufficiency (Renal Failure) 05/2020 - 03/2004
3	Cerebral Small Vessel Diseases 01/2020 - 01/2020
3	Multiple Sclerosis 01/2019 - 02/2017
3	Atherosclerotic Plaque (Atheroma) 01/2019 - 05/2014
3	Depressive Disorder (Melancholia) 01/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

71	Advanced Glycation End ProductsIBA 01/2023 - 01/2002
53	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 06/2005
43	Biomarkers (Surrogate Marker)IBA 05/2024 - 03/2006
31	Pyruvaldehyde (Methylglyoxal)IBA 05/2024 - 09/2006
28	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 01/2023 - 03/2004
19	C-Reactive ProteinIBA 12/2022 - 02/2003
16	Insulin (Novolin)FDA Link 01/2024 - 03/2002
14	Proteins (Proteins, Gene)FDA Link 11/2022 - 06/2005
14	SelectinsIBA 10/2022 - 03/2004
12	LipidsIBA 01/2023 - 07/2007
12	pentosidineIBA 10/2021 - 03/2009
11	von Willebrand FactorIBA 01/2022 - 03/2004
11	Serum Amyloid A Protein (Serum Amyloid A)IBA 10/2016 - 02/2011
10	Glyoxal (Ethanedial)IBA 02/2024 - 01/2014
10	Retinaldehyde (Retinal)IBA 10/2022 - 12/2016
10	CholesterolIBA 04/2022 - 05/2014
10	E-SelectinIBA 01/2022 - 03/2004
9	3-deoxyglucosoneIBA 02/2024 - 03/2011
9	Dietary Advanced Glycation End ProductsIBA 01/2023 - 07/2015
9	Triglycerides (Triacylglycerol)IBA 10/2020 - 05/2014
9	Lysine (L-Lysine)FDA Link 10/2020 - 02/2011
9	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020 - 05/2008
9	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 08/2015 - 06/2005
8	Complement System Proteins (Complement)IBA 01/2023 - 12/2012
8	Interleukin-8 (Interleukin 8)IBA 01/2017 - 10/2011
7	Receptor for Advanced Glycation End ProductsIBA 01/2021 - 04/2008
7	HDL CholesterolIBA 01/2020 - 05/2015
7	EnzymesIBA 01/2019 - 03/2004
6	Interleukin-6 (Interleukin 6)IBA 01/2023 - 02/2011
6	CollagenIBA 11/2022 - 01/2002
6	FructoseIBA 10/2022 - 11/2019
6	Complement C3 (C3 Complement)IBA 01/2022 - 04/2011
6	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 04/2010
5	Syntex adjuvant formulationIBA 11/2023 - 01/2017
5	AlbuminsIBA 12/2016 - 05/2002
5	ThrombomodulinIBA 03/2015 - 03/2004
5	AdipokinesIBA 06/2014 - 11/2010
4	PyridoxamineIBA 02/2023 - 01/2016
4	Complement Factor D (Factor D)IBA 01/2023 - 12/2018
4	Metformin (Glucophage)FDA LinkGeneric 10/2022 - 05/2008
4	Arginine (L-Arginine)FDA Link 10/2022 - 09/2006
4	Matrix Metalloproteinases (MMPs)IBA 07/2020 - 03/2015
4	LDL CholesterolIBA 01/2020 - 07/2007
4	OsteopontinIBA 01/2018 - 01/2013
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2016 - 11/2005
4	AdiponectinIBA 02/2013 - 06/2003
4	Plasminogen Activator Inhibitor 1IBA 03/2012 - 06/2005
4	Peptides (Polypeptides)IBA 01/2008 - 01/2005
3	SaltsIBA 10/2022 - 11/2014
3	Cell Adhesion MoleculesIBA 01/2022 - 07/2011
3	C-PeptideIBA 10/2020 - 01/2017
3	InterleukinsIBA 01/2018 - 03/2015
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 01/2008
3	hydroxide ionIBA 01/2017 - 09/2008
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2016 - 05/2008

Therapy/Procedure

7	Therapeutics 01/2022 - 09/2011
3	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2020 - 01/2019
3	Renal Dialysis (Hemodialysis) 01/2019 - 10/2013
3	Peritoneal Dialysis 01/2019 - 04/2004